110 related articles for article (PubMed ID: 9379679)
1. Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia.
Blau O; Avigad S; Stark B; Kodman Y; Luria D; Cohen IJ; Zaizov R
Leuk Res; 1997 Aug; 21(8):721-9. PubMed ID: 9379679
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of relapse in acute leukaemia: involvement of p53 mutated subclones in disease progression in acute lymphoblastic leukaemia.
Zhu YM; Foroni L; McQuaker IG; Papaioannou M; Haynes A; Russell HH
Br J Cancer; 1999 Mar; 79(7-8):1151-7. PubMed ID: 10098750
[TBL] [Abstract][Full Text] [Related]
3. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
[TBL] [Abstract][Full Text] [Related]
4. Analysis of TP53 mutations in relapsed childhood acute lymphoblastic leukemia.
Gump J; McGavran L; Wei Q; Hunger SP
J Pediatr Hematol Oncol; 2001 Oct; 23(7):416-9. PubMed ID: 11878574
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia.
Kawamura M; Kikuchi A; Kobayashi S; Hanada R; Yamamoto K; Horibe K; Shikano T; Ueda K; Hayashi K; Sekiya T
Blood; 1995 May; 85(9):2546-52. PubMed ID: 7727782
[TBL] [Abstract][Full Text] [Related]
6. [Alterations of the p53 gene and clinical features in childhood acute lymphoblastic leukemia].
Kawamua M; Hayashi Y; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Horibe K; Hongo T; Ueda K
Rinsho Ketsueki; 1997 Sep; 38(9):719-26. PubMed ID: 9364861
[TBL] [Abstract][Full Text] [Related]
7. Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia.
Felix CA; Nau MM; Takahashi T; Mitsudomi T; Chiba I; Poplack DG; Reaman GH; Cole DE; Letterio JJ; Whang-Peng J
J Clin Invest; 1992 Feb; 89(2):640-7. PubMed ID: 1737852
[TBL] [Abstract][Full Text] [Related]
8. Frequent p53 mutation in relapsed acute lymphoblastic leukemia with cytogenetic instability: a longitudinal analysis.
Tang JL; Tien HF; Lin MT; Chen PJ; Chen YC
Anticancer Res; 1998; 18(2B):1273-8. PubMed ID: 9615800
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutations and loss of a chromosome 17p in Philadelphia chromosome (Ph1)-positive acute leukemia.
Nakai H; Misawa S; Tanaka S; Nishigaki H; Taniwaki M; Yokota S; Horiike S; Takashima T; Seriu T; Nakagawa H
Leukemia; 1993 Oct; 7(10):1547-51. PubMed ID: 8412316
[TBL] [Abstract][Full Text] [Related]
10. Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia are associated with the relapse phase.
Hsiao MH; Yu AL; Yeargin J; Ku D; Haas M
Blood; 1994 May; 83(10):2922-30. PubMed ID: 8180387
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases.
Preudhomme C; Dervite I; Wattel E; Vanrumbeke M; Flactif M; Lai JL; Hecquet B; Coppin MC; Nelken B; Gosselin B
J Clin Oncol; 1995 Apr; 13(4):812-20. PubMed ID: 7707106
[TBL] [Abstract][Full Text] [Related]
12. Analysis of p16 gene mutations and deletions in childhood acute lymphoblastic leukemias.
Lemos JA; Defavery R; Scrideli CA; Tone LG
Sao Paulo Med J; 2003 Mar; 121(2):58-62. PubMed ID: 12870051
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity and somatic mutations of the glucocorticoid receptor gene are rarely found at relapse in pediatric acute lymphoblastic leukemia but may occur in a subpopulation early in the disease course.
Irving JA; Minto L; Bailey S; Hall AG
Cancer Res; 2005 Nov; 65(21):9712-8. PubMed ID: 16266991
[TBL] [Abstract][Full Text] [Related]
14. Potential role for wild-type p53 in leukemias with MLL gene translocations.
Megonigal MD; Rappaport EF; Nowell PC; Lange BJ; Felix CA
Oncogene; 1998 Mar; 16(10):1351-6. PubMed ID: 9546437
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia.
Diccianni MB; Yu J; Hsiao M; Mukherjee S; Shao LE; Yu AL
Blood; 1994 Nov; 84(9):3105-12. PubMed ID: 7949183
[TBL] [Abstract][Full Text] [Related]
16. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma.
Nomdedéu JF; Lete I; Baiget M; Lasa A; Estivill C; Rubiol E; Badell I; Pardo N; Cubells J; Mateu R; Brunet S; Bordes R; Soler J
Haematologica; 1997; 82(5):550-4. PubMed ID: 9407719
[TBL] [Abstract][Full Text] [Related]
18. Analysis of p53 mutations in a large series of lymphoid hematologic malignancies of childhood.
Wada M; Bartram CR; Nakamura H; Hachiya M; Chen DL; Borenstein J; Miller CW; Ludwig L; Hansen-Hagge TE; Ludwig WD
Blood; 1993 Nov; 82(10):3163-9. PubMed ID: 8219205
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
[TBL] [Abstract][Full Text] [Related]
20. Differentiation stages of childhood acute lymphoblastic leukemias with p53 mutations.
Felix CA; Wasserman R; Lange BJ; Brown DL; Nau MM; Cole DE; Minna JD; Poplack DG
Leukemia; 1994 Jun; 8(6):963-7. PubMed ID: 8207991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]